CoChat

Genetic Engineering of a Suboptimal Islet Graft with A20 Preserves β Cell Mass and Function

Grey, Shane T, Longo, Christopher, Shukri, Tala, Patel, Virendra I, Csizmadia, Eva, Daniel, Soizic, Arvelo, Maria B, Tchipashvili, Vaja, Ferran, Christiane · 2003 · The Journal of Immunology
Cited by 103

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Transplantation of an excessive number of islets of Langerhans (two to four pancreata per recipient) into patients with type I diabetes is required to restore euglycemia. Hypoxia, nutrient deprivation, local inflammation, and the β cell inflammatory response (up-regulation of NF-κB-dependent genes such as inos) result in β cell destruction in the early post-transplantation period. Genetic engineering of islets with anti-inflammatory and antiapoptotic genes may prevent β cell loss and primary nonfunction. We have shown in vitro that A20 inhibits NF-κB activation in islets and protects from cytokine- and death receptor-mediated apoptosis. In vivo, protection of newly transplanted islets would reduce the number of islets required for successful transplantation. Transplantation of 500 B6/AF1 mouse islets into syngeneic, diabetic recipients resulted in a cure rate of 100% within 5 days. Transplantation of 250 islets resulted in a cure rate of only 20%. Transplantation of 250 islets overexpressing A20 resulted in a cure rate of 75% with a mean time to cure of 5.2 days, comparable to that achieved with 500 islets. A20-expressing islets preserve functional β cell mass and are protected from cell death. These data demonstrate that A20 is an ideal cytoprotective gene therapy candidate for islet transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.170.12.6250

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 103

Metadata

Authors
Grey, S. T., Longo, C., Shukri, T., Patel, V. I., Csizmadia, E., Daniel, S., Arvelo, M. B., Tchipashvili, V., & Ferran, C.
Venue
The Journal of Immunology
Published
2003-06
Volume
170
Issue
12
Pages
6250-6256
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1696581921
Cited by
103
References
4
FWCI
7.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Engineering of a Suboptimal Islet Graft with A20 Preserves β Cell Mass and Function. https://app.cochat.ai/papers/10.4049/jimmunol.170.12.6250
The paper
Grey, S. T., Longo, C., Shukri, T., Patel, V. I., Csizmadia, E., Daniel, S., Arvelo, M. B., Tchipashvili, V., & Ferran, C. (2003). Genetic Engineering of a Suboptimal Islet Graft with A20 Preserves β Cell Mass and Function. The Journal of Immunology. https://doi.org/10.4049/jimmunol.170.12.6250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.